Trials / Unknown
UnknownNCT01652118
Clarithromycin Prophylaxis in Preterm Infants Colonisation With Ureaplasma Urealyticum and Mycoplasma Hominis
Prophylaxis of Bronchopulmonary Dysplasia With Clarithromycin
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 250 (estimated)
- Sponsor
- Zekai Tahir Burak Women's Health Research and Education Hospital · Academic / Other
- Sex
- All
- Age
- 1 Hour – 2 Days
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine of clarithromycin effect on developing of bronchopulmonary dysplasia in preterm babies.
Detailed description
The investigators planned that clarithromycin treatment in preterm babies who are under 1250 grams birth weight. The investigators aimed with this treatment, the bronchopulmonary dysplasia rate of preterm babies may decrease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | clarithromycin treatment for prophylaxis of bronchopulmonary dysplasia | |
| DRUG | Saline |
Timeline
- Start date
- 2011-10-01
- Primary completion
- 2012-12-01
- Completion
- 2013-01-01
- First posted
- 2012-07-27
- Last updated
- 2012-07-27
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT01652118. Inclusion in this directory is not an endorsement.